Yahoo Finance • last month
Emerging Growth MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26, 2024. The Emerging Growth Con... Full story
Yahoo Finance • 11 months ago
SAN DIEGO, December 13, 2023--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertensi... Full story
Yahoo Finance • 11 months ago
- Mr. Smith is a recognized leader in the commercialization of PAH products, most recently leading sotatercept US pre-launch activities at Merck - - Previously, Mr. Smith led US sales operations for Actelion - SAN DIEGO, December 05, 202... Full story
Yahoo Finance • 12 months ago
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Gossamer Bio, Inc. (NASDAQ: GOSS) on behalf of the company’s investors. Since December 2022, shares of Gossamer’s common stock have decli... Full story
Yahoo Finance • last year
STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Gossamer Bio, Inc. (Nasdaq: GOSS) (“Gossamer” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Go... Full story
Yahoo Finance • 2 years ago
In the last year, multiple insiders have substantially increased their holdings of Gossamer Bio, Inc. (NASDAQ:GOSS) stock, indicating that insiders' optimism about the company's prospects has increased. While insider transactions are not... Full story
Yahoo Finance • 2 years ago
CARLSBAD, Calif., October 31, 2022--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that... Full story
Yahoo Finance • 2 years ago
Shares of both AMC Entertainment Holdings Inc. and GameStop Corp. surged to multi-month highs Wednesday, as they extended breakouts above previous chart resistance levels.... Full story
Yahoo Finance • 2 years ago
Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Faheem Hasnain, recently bought a whopping US$1m worth of stock, at a price of US$7.21. While that only increased their hol... Full story
Yahoo Finance • 2 years ago
- Seralutinib (GB002) completed PAH patient enrollment in Phase 2 TORREY Study - - Topline results from Phase 2 TORREY Study expected in the fourth quarter of 2022 - - Cash, cash equivalents & marketable securities totaled $272 million a... Full story